News Category Financial ReleasesGeneral Releases Year None20222021202020192018201720162015201420132012201120102009200820072006 Date Title June 2, 2022 Supernus to Participate in the Jefferies Healthcare Conference PDF Version May 9, 2022 Supernus Announces First Quarter 2022 Financial Results PDF Version May 2, 2022 Supernus Pharmaceuticals to Announce First Quarter 2022 Financial Results and Host Conference Call on May 9, 2022 PDF Version April 29, 2022 Supernus Announces FDA Approval of Qelbree® for the Treatment of ADHD in Adults PDF Version April 13, 2022 Supernus Reports Final Audited Fourth Quarter and Full Year 2021 Financial Results PDF Version April 4, 2022 Supernus Provides Update on Filing of Annual Report and Reiterates Full Year 2022 Financial Guidance PDF Version March 17, 2022 Supernus Notifies Nasdaq Regarding Non-Compliance with Listing Requirement and Expectation to Regain Compliance PDF Version March 2, 2022 Supernus to Participate in Annual Cowen Health Care Conference PDF Version February 28, 2022 Supernus Announces Preliminary Fourth Quarter and Full Year 2021 Financial Results PDF Version February 22, 2022 Supernus to Provide Preliminary Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on February 28, 2022 PDF Version Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 11